MedTrace Logo

Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson's Disease

NCT01998204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2013-11-28

No results posted yet for this study

Summary

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. The investigators clinical experience showed a trend of delayed emergence among patients undergoing deep brain stimulator (DBS) implantation and pulse generator placement under general anesthesia. Abnormal pharmacodynamics might be present among these patients, which had never been investigated.

Conditions

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Jia-feng Wang, M.D. · Department of Anesthesiology, Changhai Hospital, Second Military Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01998204 on ClinicalTrials.gov